J. Goldman & CO LP Alnylam Pharmaceuticals, Inc. Put Options Transaction History

J. Goldman & CO LP

  • $3.21 Billion
  • Q3 2024

Put Options

3 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q3 2024

Nov 14, 2024
SELL
$233.81 - $287.01 $10.9 Million - $13.4 Million
-46,600 Reduced 92.64%
3,700 $1.02 Million
Q2 2024

Aug 14, 2024
BUY
$143.31 - $247.0 $7.21 Million - $12.4 Million
50,300 New
50,300 $12.2 Million
Q4 2022

Feb 14, 2023
BUY
$185.53 - $241.31 $3.71 Million - $4.83 Million
20,000 New
20,000 $4.75 Million

Others Institutions Holding ALNY

# of Institutions
643
Shares Held
109M
Call Options Held
1.28M
Put Options Held
1.21M
View Full List

About ALNYLAM PHARMACEUTICALS, INC.

ALNY Quotes by TradingView
  • Ticker ALNY
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 123,028,000
  • Market Cap $29.9B
  • Description
  • Alnylam Pharmaceuticals, Inc., a biopharmaceutical company, focuses on discovering, developing, and commercializing novel therapeutics based on ribonucleic acid interference. The company's pipeline of investigational RNAi therapeutics focuses on genetic medicines, cardio-metabolic diseases, hepatic infectious diseases, and central nervous system...
More about ALNY
Track This Portfolio

Track J. Goldman & CO LP Portfolio

Follow J. Goldman & CO LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of J. Goldman & CO LP, based on Form 13F filings with the SEC.

News

Stay updated on J. Goldman & CO LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email